Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Globus Medical Inc (NYSE:GMED)

23.21
BATS BZX Real-Time Price
As of 11:50am ET
 -0.64 / -2.68%
Today’s Change
20.48
Today|||52-Week Range
28.99
-16.57%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$2.3B

Company Description

Globus Medical, Inc. is a medical device company, which focuses on developing products that promote healing in patients with musculoskeletal disorders. The company also focuses on products to treat patients with spine disorders. Its products fall into two categories: Innovative Fusion and Disruptive Technologies. The Innovative Fusion products comprise fusion products to treat a wide variety of spinal disorders for the entire spine and can be used in a variety of surgical approaches. The Disruptive Technologies as those that represent a significant shift in the treatment of spinal disorders by allowing for novel surgical procedures, improvements to existing surgical procedures and the treatment of spinal disorders earlier in the continuum of care. The company was founded by David Paul, David M. Demski and David D. Davidar in March 2003 and is headquartered in Audubon, PA.

Contact Information

Globus Medical, Inc.
Valley Forge Business Center
Audubon Pennsylvania 19403
P:(610) 930-1800
Investor Relations:

Employees

Shareholders

Mutual fund holders53.60%
Other institutional49.21%
Individual stakeholders24.15%

Top Executives

David C. PaulChairman & Chief Executive Officer
Anthony L. WilliamsPresident
David D. DavidarDirector & Senior Vice President-Operations
Daniel T. ScavillaCFO, Senior VP & Head-Investor Relations
David M. DemskiDirector